
pmid: 10912299
Spasticity is a frequent feature of neurological disease in adults and children. Commonly associated symptoms include impaired movement, painful muscle spasms, stiffness and disturbed sleep. Severe or long-standing spasticity may lead to contractures and joint ankylosis, which can severely restrict the patient's care and rehabilitation. Here, we review the management of patients with spasticity, concentrating on the role of drug treatment.
Benzodiazepines, Anti-Anxiety Agents, Neuromuscular Agents, Muscle Relaxants, Central, Muscle Spasticity, Administration, Oral, Humans, Botulinum Toxins, Type A
Benzodiazepines, Anti-Anxiety Agents, Neuromuscular Agents, Muscle Relaxants, Central, Muscle Spasticity, Administration, Oral, Humans, Botulinum Toxins, Type A
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
